(Q38319178)

2 September 2017

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis (English)

1 reference

2 September 2017

1 reference

Keidar S

1

1 reference

2 September 2017

Attias J

2

1 reference

2 September 2017

Heinrich R

3

1 reference

2 September 2017

Coleman R

4

1 reference

2 September 2017

Aviram M

5

1 reference

2 September 2017

1 October 1999

1 reference

2 September 2017

1 reference

2 September 2017

146

1 reference

2 September 2017

2

1 reference

2 September 2017

249-257

1 reference

Modified forms of low density lipoprotein and atherosclerosis

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Angiotensin, LDL peroxidation and atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Human platelet angiotensin II receptors: regulation by the circulating angiotensin level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Regulation of cholesterol biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Angiotensin II signal transduction: Stimulation of multiple mitogen-activated protein kinase pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

Combination of fosinopril and pravastatin decreases platelet response to thrombin receptor agonist in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900145-8

10.1016/S0021-9150(99)00145-8

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference